BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 6196755)

  • 21. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Feasibility and relevance of tumor volumetry for stage classification and assessment of remission of germ cell tumors].
    Kreuser ED; Wellert M; Weidenmaier W; Egghart G; Hautmann R; Hetzel WD; Wolff H
    Urologe A; 1989 Nov; 28(6):344-9. PubMed ID: 2557698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.
    von Eyben FE
    Clin Biochem; 2001 Sep; 34(6):441-54. PubMed ID: 11676973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ; Bosl GJ
    J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy.
    Peckham MJ
    Prog Clin Biol Res; 1985; 203():523-38. PubMed ID: 2421341
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-seminomatous germ cell tumors of the testis. Immunohistochemical localization and serum levels of human chorionic gonadotropin (HCG) and pregnancy-specific beta-1 glycoprotein (SP-1); value of SP-1 as a tumor marker.
    Suurmeijer AJ; De Bruijn HW; Oosterhuis JW; Sleyfer DT; Koops HS; Fleuren GJ
    Oncodev Biol Med; 1982; 3(5-6):409-22. PubMed ID: 6292873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate analysis of risk factors in patients with metastatic testicular germ cell tumors treated with vinblastine and bleomycin.
    von Eyben FE; Jacobsen GK; Pedersen H; Jacobsen M; Clausen PP; Zibrandtsen PC; Gullberg B
    Invasion Metastasis; 1982; 2(2):125-35. PubMed ID: 6203868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. It is rational to measure serum lactate dehydrogenase isoenzyme-1 activity in patients with testicular germ cell tumours.
    von Eyben FE; Hyltoft Petersen P; Blaabjerg O; Lindegaard Madsen E
    Eur J Clin Chem Clin Biochem; 1997 Dec; 35(12):943. PubMed ID: 9476626
    [No Abstract]   [Full Text] [Related]  

  • 36. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 37. Lactate dehydrogenase isoenzyme 1 (LDH-1) in athymic mice with xenografts of a human testicular germ cell tumor.
    von Eyben FE; Skude G; Tropé C; Wennerberg J; Mikulowski P
    Mol Gen Genet; 1982; 186(3):427-31. PubMed ID: 6289049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
    Winkle DC; Clague AE; Gardiner RA
    Aust N Z J Surg; 1988 Sep; 58(9):737-41. PubMed ID: 2854968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.